Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Year-over-year book value per share growth
Percentile
P41
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -11.02% |
| Q3 2025 | -7.61% |
| Q2 2025 | -12.20% |
| Q1 2025 | 2.07% |
| Q4 2024 | -8.64% |
| Q3 2024 | -5.48% |
| Q2 2024 | 5.64% |
| Q1 2024 | 11.83% |
| Q4 2023 | -16.70% |
| Q3 2023 | 6.38% |
| Q2 2023 | -17.41% |
| Q1 2023 | 2.91% |
| Q4 2022 | 21.55% |
| Q3 2022 | -16.99% |
| Q2 2022 | -14.45% |
| Q1 2022 | -11.31% |
| Q4 2021 | -11.78% |
| Q3 2021 | -7.25% |
| Q2 2021 | 10.21% |
| Q1 2021 | -1.97% |
| Q4 2020 | -7.77% |
| Q3 2020 | -14.67% |
| Q2 2020 | 196.23% |
| Q1 2020 | -18.81% |
| Q4 2019 | -17.29% |
| Q3 2019 | -11.00% |
| Q2 2019 | -8.74% |
| Q1 2019 | -9.98% |
| Q4 2018 | 46.45% |
| Q3 2018 | -10.85% |
| Q2 2018 | -13.55% |
| Q1 2018 | 73.55% |
| Q4 2017 | -23.49% |
| Q3 2017 | 26.33% |
| Q2 2017 | -14.07% |
| Q1 2017 | -10.43% |
| Q4 2016 | -11.34% |
| Q3 2016 | -18.07% |
| Q2 2016 | 81.49% |
| Q1 2016 | -13.00% |